Ctlevo-MT
Description_Effects
Ctlevo-MT is a combination medicine containing Levocetirizine and Montelukast, designed to provide effective relief from symptoms associated with allergies and respiratory conditions. This formulation is commonly used to treat conditions such as allergic rhinitis, hay fever, sneezing, runny or blocked nose, nasal congestion, watery eyes, and itching. It is also beneficial in managing asthma symptoms and improving overall respiratory function. Levocetirizine is a second-generation antihistamine that works by blocking histamine, a chemical released by the body during allergic reactions. This helps control sneezing, itching, and watery eyes without causing much drowsiness. Montelukast is a leukotriene receptor antagonist that inhibits the action of leukotrienes, inflammatory mediators that cause swelling in the airways, tightening of chest muscles, and increased mucus production. Together, these two medicines work synergistically to reduce inflammation, ease breathing, and relieve allergic symptoms more effectively than either drug alone. Ctlevo-MT is typically taken once daily, and its use should be guided by a healthcare professional. Regular use may help improve quality of life in patients with chronic allergic or respiratory conditions by controlling symptoms and preventing flare-ups.
